SHANNON ZAMBONI: Open Payments
NPI 1023005303 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$791 in 42 payments from 11 companies in 2025. Trend: 2023 $716 · 2024 $868 · 2025 $791
Food & beverage: $791
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $287 |
| GlaxoSmithKline, LLC. | 9 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $92 |
| ABBVIE INC. | 3 | $60 |
| Amgen Inc. | 2 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Novo Nordisk Inc | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| Lilly USA, LLC | 1 | $15 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $15 |
Products named: NURTEC ODT, TRELEGY ELLIPTA, JARDIANCE, VRAYLAR, OTEZLA, PREVNAR 20, Wegovy, Symbravo.
Industry payments across NV — which companies pay providers there.
